GSK PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,633.50 GBX | -0.31% |
|
-1.09% | +12.64% |
| 09-13 | Moderna's Faces 'Material Headwinds' on RSV, COVID, RBC Says | MT |
| 09-13 | GSK Bets on Blood-Cancer Drug Comeback Amid Oncology Push | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 87.58B | ||||||
| 832B | ||||||
| 605B | ||||||
| 398B | ||||||
| 343B | ||||||
| 294B |
- Stock Market
- Equities
- GSK Stock
- Charts GSK plc
- Sector Chart
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition